Published in J Am Coll Cardiol on July 01, 1995
Saxagliptin and Acute Myocardial Infarction:Effects on Platelet Function | NCT02377388
Barriers to the Implementation of Complete Insulin Order Sets | NCT00813280
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med (2012) 3.67
Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes. Diabetes (2015) 2.87
How does blood glucose control with insulin save lives in intensive care? J Clin Invest (2004) 2.65
Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes (2008) 2.41
Insulin infusion in diabetic patients with acute myocardial infarction. BMJ (1996) 2.02
Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax (2006) 1.96
Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak (2005) 1.76
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol (2010) 1.55
Safety and efficacy of continuous insulin infusion in noncritical care settings. J Hosp Med (2010) 1.51
Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care (2013) 1.51
Association of stress hyperglycemia and atrial fibrillation in myocardial infarction. Wien Klin Wochenschr (2008) 1.51
Beneficial haemodynamic effects of insulin in chronic heart failure. Heart (2001) 1.50
Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Cell Metab (2006) 1.50
Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med (2011) 1.48
Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points. Diab Vasc Dis Res (2008) 1.48
Tight Glycemic Control With Insulin Does Not Affect Skeletal Muscle Degradation During the Early Postoperative Period Following Pediatric Cardiac Surgery. Pediatr Crit Care Med (2015) 1.46
A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart (2003) 1.35
Moving beyond tight glucose control to safe effective glucose control. Crit Care (2008) 1.33
Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario. J Diabetes Sci Technol (2010) 1.28
Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial. Can Fam Physician (2008) 1.18
Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia (2010) 1.18
Benchmarking glucose results through automation: the 2009 Remote Automated Laboratory System Report. J Diabetes Sci Technol (2010) 1.12
The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke. Int J Stroke (2013) 1.09
Inpatient diabetology. The new frontier. J Gen Intern Med (2004) 1.08
Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists! Diabetes Care (2013) 1.06
Glycemic control for postoperative pediatric cardiac patients. Pediatr Cardiol (2009) 1.06
Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am (2012) 1.04
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol (2012) 1.04
Insulin therapy in critically ill patients. Vasc Health Risk Manag (2010) 1.00
Hyperglycaemia and mortality. J R Soc Med (2007) 0.99
The Japanese guidelines for the management of sepsis. J Intensive Care (2014) 0.99
Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease. Vasc Health Risk Manag (2008) 0.96
Reducing glycemic variability in intensive care unit patients: a new therapeutic target? J Diabetes Sci Technol (2009) 0.96
Is insulin an endogenous cardioprotector? Crit Care (2002) 0.94
Diabetic heart disease: clinical considerations. Heart (2001) 0.94
Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? Crit Care (2009) 0.93
Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction. Cardiovasc Diabetol (2007) 0.92
Myocardial protection in man--from research concept to clinical practice. Heart Fail Rev (2007) 0.92
Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]. Crit Care (2005) 0.92
Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry. Cardiovasc Diabetol (2010) 0.92
Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci (2010) 0.92
Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol (2000) 0.91
Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project. Diabetes Care (2008) 0.90
Evaluation of the VIA Blood Chemistry Monitor for Glucose in Healthy and Diabetic Volunteers. J Diabetes Sci Technol (2008) 0.89
Diabetes mellitus, acute hyperglycemia, and ischemic stroke. Curr Treat Options Neurol (2010) 0.89
The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Cardiovasc Diabetol (2012) 0.89
Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg (2006) 0.89
Modern risk stratification in coronary heart disease. J Med Life (2011) 0.88
Importance of measuring glycosylated hemoglobin in patients with myocardial infarction and known diabetes mellitus. Am J Cardiol (2010) 0.88
Review of insulin therapy and pen use in hospitalized patients. Hosp Pharm (2013) 0.87
The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes. Cardiovasc Diabetol (2013) 0.87
Is there a relationship between admission blood glucose level following acute poisoning and clinical outcome? Arch Med Sci (2011) 0.87
An overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol (2009) 0.86
Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes. Heart (1999) 0.86
Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction. Heart (2003) 0.84
Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes? Diab Vasc Dis Res (2009) 0.84
Glycemic Control during Coronary Artery Bypass Graft Surgery. ISRN Cardiol (2012) 0.84
The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]. BMC Med (2005) 0.83
Effects of Glucose Concentration on Propofol Cardioprotection against Myocardial Ischemia Reperfusion Injury in Isolated Rat Hearts. J Diabetes Res (2015) 0.83
Acute in vivo performance evaluation of the fluorescence affinity sensor in the intravascular and interstitial space in Swine. J Diabetes Sci Technol (2013) 0.82
Predicting mortality of critically ill patients by blood glucose levels. Diabetes Metab J (2013) 0.82
Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study. BMJ Open (2012) 0.82
Glucose and potassium derangements by glucose-insulin-potassium infusion in acute myocardial infarction. Neth Heart J (2006) 0.82
Strict glucose control in the critically ill. BMJ (2006) 0.81
Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis. Cardiovasc Diabetol (2016) 0.81
Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial. Trials (2011) 0.80
How to best manage glycemia and non-glycemia during the time of acute myocardial infarction. Diabetes Technol Ther (2012) 0.80
Clinical controversies in the management of critically ill patients with severe sepsis: resuscitation fluids and glucose control. Virulence (2013) 0.80
The effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic review. BMC Nurs (2005) 0.80
Should we treat prehypertension in diabetes? What are the cons? Diabetes Care (2009) 0.80
Treating hyperglycemia and diabetes with insulin therapy: transition from inpatient to outpatient care. Medscape J Med (2008) 0.79
The Euro Heart Survey - Germany: diabetes mellitus remains unrecognized in patients with coronary artery disease. Clin Res Cardiol (2008) 0.79
The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome. Neth Heart J (2011) 0.79
Glycemic variability and glycemic control in the acutely ill cardiac patient. Heart Fail Clin (2012) 0.79
Personalizing guidelines for diabetes management: twilight or dawn of the expert? BMC Med (2013) 0.78
Impact of admission blood glucose levels on prognosis of elderly patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention. J Geriatr Cardiol (2013) 0.78
Efficacy of a continuous GLP-1 infusion compared with a structured insulin infusion protocol to reach normoglycemia in nonfasted type 2 diabetic patients: a clinical pilot trial. Diabetes Care (2009) 0.78
Emerging therapies in severe sepsis. Thorax (2002) 0.77
Mortality after myocardial infarction in patients with diabetes mellitus. Heart (2007) 0.77
Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure. Heart (2006) 0.77
Treating Diabetes Mellitus: Pharmacophore Based Designing of Potential Drugs from Gymnema sylvestre against Insulin Receptor Protein. Biomed Res Int (2016) 0.77
Glucose-insulin-potassium infusion in sepsis and septic shock: no hard evidence yet. Crit Care (2002) 0.77
Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial. Diabetes Care (2011) 0.77
Emergency management of acute myocardial infarction. Br J Clin Pharmacol (1999) 0.77
Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care (2014) 0.76
Tight glycaemic control in acute exacerbations of COPD. Thorax (2006) 0.76
Glycemic control and organ transplantation. J Diabetes Sci Technol (2009) 0.76
Prevalence of stress hyperglycemia among hepatopancreatobiliary postoperative patients. Int J Clin Exp Med (2013) 0.76
Pediatrics: Intensive insulin therapy in critically ill children. Nat Rev Endocrinol (2009) 0.75
Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients. J Diabetes Sci Technol (2015) 0.75
Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI. Pak J Med Sci (2015) 0.75
Impacts of insulin infusion protocol on blood glucose level and outcomes in acute coronary syndrome patients with diabetes mellitus. Iran J Nurs Midwifery Res (2015) 0.75
Update on inpatient diabetes management: call for action. Diabetes Technol Ther (2015) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med (1984) 4.51
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med (1992) 4.37
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med (1997) 3.49
[Acute coronary syndromes. Simplified routines with early exercise test performed at the intensive coronary care units]. Lakartidningen (1993) 3.19
Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation (2000) 3.12
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Multivariate analysis of risk factors for coronary heart disease. Circulation (1973) 3.04
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J (2004) 2.80
Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J Infect Dis (1977) 2.72
The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J (2002) 2.68
Accelerated nodulosis, pleural effusion, and pericardial tamponade during methotrexate therapy. J Rheumatol (1994) 2.62
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Reaction mechanism of the alternative pathway of complement fixation. Lancet (1973) 2.38
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1996) 2.31
Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet (1985) 2.26
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation (1982) 2.22
Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med (2008) 2.21
Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J (1999) 2.16
Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation (1997) 2.13
Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res (1999) 2.11
Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor. Ann Oncol (2012) 2.02
Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Eur J Surg Oncol (2013) 1.99
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia (2006) 1.90
Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90
Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes (1972) 1.88
The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J (1996) 1.83
A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis (1976) 1.80
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med (1997) 1.79
Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med (1999) 1.76
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J (1997) 1.76
Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost (2007) 1.74
Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care (1999) 1.72
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
The reaction of salivary substances with bacteria. J Oral Pathol (1975) 1.66
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol (1992) 1.66
Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol (1998) 1.66
Stressful life events, social support, and mortality in men born in 1933. BMJ (1993) 1.66
The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish population. JAMA (1994) 1.64
Quality management in resuscitation--towards a European cardiac arrest registry (EuReCa). Resuscitation (2011) 1.64
New concept in echocardiography: harmonic imaging of tissue without use of contrast agent. Lancet (1998) 1.64
Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest (1997) 1.63
Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med (1992) 1.62
Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'. Arch Intern Med (1997) 1.62
Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99. J Intern Med (2004) 1.62
Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation (2001) 1.62
Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ (1989) 1.61
High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis (1998) 1.61
Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. Eur Heart J (2000) 1.60
Effect of bystander cardiopulmonary resuscitation in out-of-hospital cardiac arrest patients in Sweden. Resuscitation (2000) 1.59
Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol (1986) 1.55
Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J (1992) 1.55
Falls risk factors in an acute-care setting: a retrospective study. Can J Nurs Res (1998) 1.55
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J (2003) 1.53
Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia (1988) 1.53
Coronary heart disease and mortality in middle aged men from different occupational classes in Sweden. BMJ (1988) 1.53
A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment. J Intern Med (2002) 1.52
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol (1991) 1.52
Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia (1993) 1.51
Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting. Eur Heart J (1996) 1.51
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ (1990) 1.50